Top View
- Pharmacological Actions of Statins: a Critical Appraisal in the Management of Cancer
- Statins: HMG-Coa Reductase Inhibitors As Potential Anticancer Agents Against Malignant Neoplasms in Women
- Supplementary Figures
- Estrogen Receptor–Negative Breast Cancer Is Less Likely to Arise Among Lipophilic Statin Users
- Determination of Lovastatin, Mevastatin, Rosuvastatin and Simvastatin with HPLC by Means of Gradient Elution
- Wo 2010/065069 A2
- Statins Increase Plasminogen Activator Inhibitor Type 1 Gene Transcription Through a Pregnane X Receptor Regulated Element
- Production and Optimization of Mevastatin Using Penicillium Citrinum NCIM 768 Narayanan Mahesh1*, Srinivasan Balakumar1, P
- Predicting Drug Responses by Propagating Interactions Through Text-Enhanced Drug-Gene Networks
- WO 2008/112887 Al
- Statin-Related Myotoxicity: a Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle Components
- View (E39) Richard Ofori-Asenso, Ella Zomer, Andrea Curtis, Andrew Tonkin, Mark Nelson, Manoj Gambhir, Danny Liew, Sophia Zoungas
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Detection of 4A,5-Dihydropravastatin As Impurity in the Cholesterol Lowering Drug Pravastatin
- Emerging Pollutants a Brief Overview
- Lipid Management in Patients with Endocrine Disorders: an Endocrine
- Mevastatin-Induced Apoptosis and Growth Suppression in U266 Myeloma Cells
- In Vivo and in Vitro Effects of Statins on Lymphocytes in Patients With
- Lovastatin, an Inhibitor of Cholesterol Synthesis, Induces
- Statin As a Potential Chemotherapeutic Agent: Current Updates As a Monotherapy, Combination Therapy, and Treatment for Anti-Cancer Drug Resistance
- Customs Tariff - Schedule Xxi - 1
- Ciglitazone, an Agonist of Peroxisome Proliferator-Activated Receptor Γ
- A Simultaneous Assessment of CYP3A4 Metabolism and Induction in the DPX-2 Cell Line Submitted: August 12, 2004; Accepted: October 20, 2004; Published: March 4, 2005
- Molecular Mechanisms of Toxicity of Simvastatin, Widely Used Cholesterol-Lowering Drug
- Microbial Drug Discovery: 80 Years of Progress
- Topical Mevastatin Promotes Wound Healing by Inhibiting the Transcription Factor C-Myc Via the Glucocorticoid Receptor and the Long Noncoding RNA Gas5
- A Small Molecule Drug Screening Identifies Colistin Sulfate As an Enhancer of Natural Killer
- Harmonized Tariff Schedule of the United States (2006) (Rev
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances 2009
- WO 2015/111029 Al 30 July 2015 (30.07.2015) P O P C T
- The Effect of Statin Therapy on Thyroid Autoimmunity in Patients With
- (12) United States Patent (10) Patent No.: US 8.445,538 B2 Lin Et Al
- Lipid Metabolism and Resistance to Anticancer Treatment
- Synthetic Studies Towards Steroid Intermediate, Lipoic Acid and Other Biologically Active Compounds
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Supplementary Material
- Download Product Insert (PDF)
- (12) United States Patent (10) Patent No.: US 7,199,126 B2 Griffin Et Al
- FERROPTOSIS: a New Form of Cell Death
- Regulation of Osteoclast Differentiation and Activity by Lipid Metabolism
- Mevastatin Blockade of Autolysosome Maturation Stimulates LBH589-Induced Cell Death in Triple-Negative Breast Cancer Cells
- (12) Patent Application Publication (10) Pub. No.: US 2010/0009970 A1 Johansen Et Al
- 200153Orig1s000